As the beauty and regenerative medicine industries move toward ethical and high-performance alternatives to animal-derived ingredients, CD BioGlyco leads the way with our recombinant human-like collagen production service. Unlike traditional collagen extracted from bovine or porcine tissues, which carries risks of immunogenicity and viral transmission, our recombinant human-like collagen is synthesized using advanced synthetic biology and yeast fermentation platforms. This "human-like" collagen is specifically engineered to match the repetitive amino acid sequences found in human collagen types, ensuring high water solubility, superior biocompatibility, and optimal cell-adhesion properties. At CD BioGlyco, we bridge the gap between complex biotechnology and commercial cosmetic applications, providing a stable, high-purity, and high-titer supply of collagen that serves as the gold standard for anti-aging and skin repair formulations.
Core Technologies
We utilize a multi-disciplinary technology stack to engineer superior collagen molecules:
High-Density Microbial Fermentation
We utilize optimized Pichia pastoris and E. coli systems that enable the high-yield secretion of collagen polypeptides, reducing production costs compared to mammalian cell cultures.
Modular Gene Assembly
Our scientists use synthetic biology tools to assemble collagen genes with specific repeats of Gly-X-Y motifs, allowing for the customization of molecular weight and mechanical properties.
Post-Translational Hydroxylation Engineering
By co-expressing human prolyl 4-hydroxylase (P4H) within our microbial hosts, we ensure the essential hydroxylation of proline residues required for triple-helix stability.
Advanced Yeast Secretion Signals
Proprietary signal peptides are integrated into the expression vectors to ensure that the recombinant collagen is efficiently secreted into the culture medium, simplifying downstream purification.
Precision Structural Characterization
We employ Circular Dichroism (CD) and FTIR spectroscopy to verify the secondary structure and thermal stability of every batch, ensuring it meets physiological performance standards.
Engineering the Structural Blueprint of Youthful Skin.
The recombinant human-like collagen production service provides a comprehensive solution for cosmetic formulators and biomedical researchers seeking the highest grade of bioactive structural proteins. Our service scope covers the entire lifecycle of collagen development, from initial in-silico protein modeling to large-scale industrial manufacturing. We specialize in the production of type I and type III human-like collagen, which are essential for skin firmness and elasticity. Our platform is capable of producing full-length collagen chains as well as specialized collagen-mimetic peptides designed for deep dermal penetration.
We offer custom expression host selection, allowing clients to choose between plant-based molecular farming for "vegan" branding or yeast-based fermentation for high-yield medical applications. We also provide structural modification services, including the tailoring of cross-linking sites to adjust the degradation rate of the collagen in topical or injectable formulations. Our scope extends to stability and compatibility testing, where we evaluate how our recombinant human-like collagen interacts with common cosmetic ingredients like hyaluronic acid, vitamins, and preservatives. We ensure that our clients receive a product that is not only pure but also biologically functional, stimulating endogenous collagen synthesis and enhancing the skin's natural repair mechanisms. We provide flexible production volumes, ranging from pilot-scale R&D batches to multi-ton commercial supplies, supported by rigorous regulatory documentation for global market entry.
Workflow
Our end-to-end production service follows a rigorous scientific pathway to ensure quality and scalability.
Sequence Design & Codon Optimization
We design the human-like collagen sequence based on client specifications (e.g., type I or III motifs) and optimize codons for maximum expression efficiency in the selected microbial chassis.
Strain Construction & Screening
The synthetic gene is integrated into the host genome. We perform high-throughput screening of transformants to identify "super-secretor" clones with the highest protein titers and stability.
Scale-up Fermentation
Optimized strains are transitioned from shake flasks to industrial-scale bioreactors, where we control oxygen transfer, nutrient feeding, and pH to achieve high cell density and maximum protein accumulation.
Downstream Purification
Utilizing a combination of ultrafiltration and multi-step liquid chromatography (ion exchange and hydrophobic interaction), we isolate the recombinant human-like collagen from host cell proteins and DNA to achieve >95% purity.
Polishing & Lyophilization
The purified protein is filtered through medical-grade membranes to ensure sterility and then freeze-dried into a highly soluble white powder, suitable for diverse cosmetic and medical vehicles.
Comprehensive Quality Control
Every lot undergoes testing for molecular weight, purity, heavy metals, and bioactivity (such as cell proliferation assays) to provide a complete certificate of analysis (CoA).
Publication Data
Journal: Journal of Dermatologic Science and Cosmetic Technology
DOI: 10.1016/j.jdsct.2024.100059
Published: 2024
Results: This review article provides a comprehensive overview of the application of recombinant collagen in the cosmetics industry. The authors detail the classification of recombinant collagen (recombinant human collagen, humanized collagen, and collagen-like proteins) and highlight its significant advantages over traditional animal-derived sources, including superior biocompatibility, absence of zoonotic disease risk, and customizable production. The paper systematically compares various recombinant expression systems, such as yeast, plants, E. coli, and transgenic animals, analyzing their respective benefits and limitations for scalable manufacturing. Furthermore, it summarizes the proven and potential efficacy of recombinant collagen in key cosmetic applications, including combating skin aging, promoting skin regeneration, and aiding in repair and general skincare. The review concludes that recombinant collagen, produced via genetic engineering, is a promising, safer, and high-performance alternative to animal-derived collagen, with a growing impact on the beauty and personal care markets.
Applications
Post-Procedural Repair Creams
Formulating soothing topicals for use after microneedling, chemical peels, or laser treatments, where the non-immunogenic nature of recombinant human-like collagen supports rapid re-epithelialization and barrier repair.
Hydrating Color Cosmetics
Adding functional collagen to foundations and primers to improve skin hydration and create a smooth, "second skin" effect that prevents makeup from settling into pores.
Professional Scalp and Hair Care
Incorporating recombinant human-like collagen into scalp treatments to strengthen the hair follicle environment and improve the elasticity of the scalp, promoting healthier-looking hair growth.
Eco-Conscious Vegan Beauty Lines
Providing a certified animal-free collagen source for brands that want to offer high-performance regenerative benefits while adhering to strict vegan and cruelty-free standards.
Advantages
High Water Solubility and Clarity
Unlike traditional animal collagen, which often requires acidic conditions for solubility, our recombinant human-like collagen is highly soluble in water at neutral pH, allowing for crystal-clear and elegant cosmetic formulations.
Sustainable and Ethical Sourcing
Our microbial and plant-based production platforms represent a "clean beauty" solution with a lower carbon footprint than livestock-based protein extraction, appealing to eco-conscious consumers.
Enhanced Dermal Penetration
We offer low-molecular-weight recombinant human-like collagen options specifically engineered to bypass the skin barrier more effectively, delivering bioactive signals directly to the deeper layers of the dermis.
Synergistic Formulation Compatibility
Our collagen remains stable in the presence of a wide range of surfactants and actives, making it a versatile "hero ingredient" for everything from serums to high-performance sunscreens.
Frequently Asked Questions
Customer Review
"CD BioGlyco's recombinant human-like collagen has transformed our anti-aging line. The solubility is miles ahead of the bovine collagen we used to use, and our customers love the 'clean' origin."
– Dr. A.L., Director of R&D
"We observed a 40% faster recovery in skin barrier function when using the CD BioGlyco collagen formula after chemical peels. The data is truly impressive."
– Manager, Clinical Studies
"The odorless nature of this collagen is a game-changer. We can finally create high-performance serums without needing heavy perfumes to mask the protein smell."
– Dr. J.W., Senior Formulator
"Switching to CD BioGlyco allowed us to achieve our '100% Vegan' certification without losing the biological power of real collagen."
– VP of Innovation
"The batch-to-batch consistency is outstanding. We get the same molecular weight every time, which makes our manufacturing process much more predictable."
Nanofiltration and ultrafiltration for the concentration and purification of large biopolymers.
CD BioGlyco serves as your strategic innovation partner, guiding the seamless transition to ethical, sustainable, and high-performance biotechnology. Our proprietary recombinant human-like collagen is scientifically designed to meet the most rigorous quality, safety, and efficacy standards demanded by the global aesthetics, medical, and advanced skincare markets. As a vegan, biocompatible, and consistently pure ingredient, it enables brands to achieve superior product performance while upholding responsible and transparent values. Contact us today to explore how our platform can elevate your next groundbreaking formulation.
Reference
Chen, C.X.; et al. An overview of progress in the application of recombinant collagen in cosmetics. Journal of Dermatologic Science and Cosmetic Technology. 2024, 1(4): 100059. (Open Access)
For research use only. Not intended for any clinical use.
